Bain Capital is in talks to acquire Mitsubishi Chemical Group's pharmaceutical business in a potential multibillion-dollar deal, a person familiar with the matter said, a transaction that could ...
Zacks.com on MSN1h
Denali Gains 26.6% in a Year: How Should You Play the Stock?Denali Therapeutics DNLI has performed well in the past 12 months amid a volatile market. Shares of the company have gained ...
The approval of Calquence marks the first and only BTK inhibitor approved for the first-line treatment of MCL in the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback